Navigating Your First Mounjaro Dose: A Step-by-Step Guide

Last reviewed: July 11, 2026

Last updated: July 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Tirzepatide, a dual GLP-1 and GIP receptor agonist, produces weight loss by reducing hunger and regulating blood sugar—with clinical trials showing up to 22% body weight reduction in patients. Starting this medication safely means understanding your initial dose, timing your injections, and recognizing what sensations are normal during the first few weeks. PlexusDx guides you through every step of beginning tirzepatide therapy.

Understanding Your Starting Tirzepatide Dose

Your first tirzepatide injection typically begins at a low starting dose—usually 2.5 mg per week—to allow your body to adjust to the medication's effects. This cautious approach reduces nausea, loss of appetite, and gastrointestinal side effects that can occur when doses are escalated too quickly. PlexusDx structures your initial prescription to prioritize tolerance while still engaging the pathways responsible for appetite suppression and metabolic improvement.

The PlexusDx Precision Peptide Genetic Test analyzes GLP1R, and GIPR — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Mounjaro or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Preparing for Your First Injection

Before your first tirzepatide injection arrives, prepare your injection supplies and choose a consistent day and time each week—typically Sunday evening works well since it leaves weekdays for any mild adjustment symptoms. Store your medication in the refrigerator between 36–46°F, and allow it to warm to room temperature for 15–30 minutes before injecting to reduce injection discomfort. Gather alcohol pads, a sharps container, and review the injection technique video PlexusDx provides to ensure you're confident with the subcutaneous injection method.

On injection day, rotate your injection sites between your abdomen, thigh, and upper arm to prevent irritation or lipohypertrophy—a thickening of fatty tissue that can occur with repeated injections in the same location. Keep a simple log noting the date, site, and any sensations you experience; this record helps your PlexusDx provider understand your tolerance and adjust your protocol if needed.

What to Expect During Your First Week

In the first 24–48 hours after your initial injection, you may notice reduced appetite, mild nausea, or a subtle change in how foods taste—particularly fatty or sweet items. These effects typically peak within the first week and improve significantly as your body adjusts. Many patients report that the hunger suppression is gentle rather than dramatic at the starting dose, allowing them to eat normally while feeling satisfied with smaller portions.

Some people experience mild constipation or slight fatigue during week one, both manageable with increased water intake and gentle movement. Avoid making major dietary changes during this period; instead, let tirzepatide's natural appetite-suppressing effects guide your eating patterns. If side effects feel intolerable, contact your PlexusDx care team immediately—they may adjust your dose or suggest timing strategies to improve your experience.

Building Your Tirzepatide Protocol with PlexusDx

PlexusDx structures tirzepatide therapy as a personalized protocol rather than a one-size-fits-all regimen. Your compounded tirzepatide injection starts at $289/mo (or $249/mo on the 6-month plan) with a flat monthly rate—your dose may increase over weeks, but your price remains consistent. This pricing model removes the barrier of escalating costs as your provider titrates your medication upward, making long-term treatment predictable and affordable.

Approximately one month into therapy, PlexusDx recommends the Precision Peptide Genetic Test ($99 add-on) to map your genetic predispositions across 14 peptide pathways and 150+ insights. Results reveal how efficiently your body processes GLP-1, GIP, and related signaling molecules, helping your provider determine whether you'll benefit from staying on tirzepatide, adding a complementary compound, or exploring the dual-compound GLP-Squared option. This precision approach transforms tirzepatide from a standard prescription into a truly individualized weight loss solution.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $289/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Will my tirzepatide dose increase every week?

No. Your starting dose remains stable for 4 weeks before your provider considers an increase based on your tolerance and response. Dose escalations happen gradually—typically increasing by 2.5 mg every 4 weeks—with the timeline customized to your individual adjustment. PlexusDx monitors your feedback and adjusts pacing to ensure safety and comfort.

What makes PlexusDx tirzepatide different from other sources?

PlexusDx compounds tirzepatide in licensed 503A pharmacies, meaning the medication is compounded specifically for you under strict pharmaceutical standards. Your therapy includes personalized dosing guidance, genetic testing options, and ongoing provider adjustments—not just a prescription shipped in bulk.

Can I use my HSA or FSA to pay for tirzepatide from PlexusDx?

Yes. PlexusDx tirzepatide injections are HSA/FSA eligible, and the Precision Peptide Genetic Test qualifies as well, making your treatment more accessible. No insurance is required, and PlexusDx serves all 50 states.

What if tirzepatide causes too much nausea at the starting dose?

Contact your PlexusDx provider immediately if nausea is severe. Options include adjusting injection timing, eating smaller meals beforehand, or temporarily pausing escalation until your body adjusts. Severe nausea within the first week is uncommon at the 2.5 mg starting dose and usually signals a need for protocol adjustment rather than medication discontinuation.

How does the Precision Peptide Genetic Test help with tirzepatide dosing?

No — the Precision Peptide Genetic Test does not predict your response to GLP-Squared or any specific medication. It analyzes pathway-level variants (GLP1R, GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension
• Mounjaro For Endometriosis

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.